Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07264920 · ClinicalTrials.gov registry record · NA
Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain
A NA study, sponsored by Johns Hopkins University.
- Not yet
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT07264920: Clinical Trial NA study, sponsored by Johns Hopkins University.
NCT07264920 is a NA study that has not yet begun recruiting, run by Johns Hopkins University. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07264920, a NA study, has not yet begun recruiting, sponsored by Johns Hopkins University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This is a study evaluating the Scrambler Therapy device as a non-invasive treatment for neuropathic pain in pediatric oncology patients with metastatic bone disease. The primary goal is to assess changes in pain intensity and medication use, aiming to improve quality of life and reduce reliance on systemic pain medications.
Primary Outcome
The primary outcome is the change in self-reported pain intensity from baseline (prior to the first Scrambler Therapy session) to the post-final Scrambler Therapy session as measured by Numerical Rating Scale (NRS) or Wong-Baker Faces Pain Scale. The patients will rate pain using one of these scales at the beginning and the end of each treatment session with the primary comparison between the pre-first treatment session and the post-final treatment session. Total score range from 0-10, for both
Interventions
- DEVICE Scrambler Therapy MC-5A Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-08 |
| Est. Completion | 2030-01 |
| Phase | NA |
What is known before NCT07264920 opens enrollment
NCT07264920 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Scrambler Therapy MC-5A Device is the first listed.
NCT07264920 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07264920 about?
NCT07264920 is a clinical study titled "Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain". This is a study evaluating the Scrambler Therapy device as a non-invasive treatment for neuropathic pain in pediatric oncology patients with metastatic bone disease. The primary goal is to assess changes in pain intensity and medication use, aiming to improve quality of life and reduce reliance on s...
What is the current status of trial NCT07264920?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-08. Estimated completion is 2030-01.
What interventions are being tested in trial NCT07264920?
The interventions under investigation include: Scrambler Therapy MC-5A Device (DEVICE).
Who is sponsoring clinical trial NCT07264920?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07264920's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia